3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors

Details for Australian Patent Application No. 2005313485 (hide)

Owner Johannes Gutenberg-Universitat Mainz

Inventors Dannhardt, Gerd; Plutizki, Stanislav; Peifer, Christian; Kramb, Jan-Peter

Agent Freehills

Pub. Number AU-B-2005313485

PCT Pub. Number WO2006/061212

Priority 04029069.4 08.12.04 EP

Filing date 7 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 3 February 2011

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/061212 Priority application(s): WO2006/061212

3 February 2011 Application Accepted

  Published as AU-B-2005313485

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313492-IL-7 variants with reduced immunogenicity

2005313481-Sensor for detection of carbohydrate